A paradox for tiny probabilities and enormous values

Nick Beckstead (Open Philanthropy Project) and Teruji Thomas (Global Priorities Institute, Oxford University)

GPI Working Paper No. 7-2021, published in Noûs

We show that every theory of the value of uncertain prospects must have one of three unpalatable properties. Reckless theories recommend risking arbitrarily great gains at arbitrarily long odds for the sake of enormous potential; timid theories permit passing up arbitrarily great gains to prevent a tiny increase in risk; non-transitive theories deny the principle that, if A is better than B and B is better than C, then A must be better than C. While non-transitivity has been much discussed, we draw out the costs and benefits of recklessness and timidity when it comes to axiology, decision theory, and moral uncertainty.

Other working papers

Calibration dilemmas in the ethics of distribution – Jacob M. Nebel (University of Southern California) and H. Orri Stefánsson (Stockholm University and Swedish Collegium for Advanced Study)

This paper presents a new kind of problem in the ethics of distribution. The problem takes the form of several “calibration dilemmas,” in which intuitively reasonable aversion to small-stakes inequalities requires leading theories of distribution to recommend intuitively unreasonable aversion to large-stakes inequalities—e.g., inequalities in which half the population would gain an arbitrarily large quantity of well-being or resources…

Estimating long-term treatment effects without long-term outcome data – David Rhys Bernard (Paris School of Economics)

Estimating long-term impacts of actions is important in many areas but the key difficulty is that long-term outcomes are only observed with a long delay. One alternative approach is to measure the effect on an intermediate outcome or a statistical surrogate and then use this to estimate the long-term effect. …

Meaning, medicine and merit – Andreas Mogensen (Global Priorities Institute, Oxford University)

Given the inevitability of scarcity, should public institutions ration healthcare resources so as to prioritize those who contribute more to society? Intuitively, we may feel that this would be somehow inegalitarian. I argue that the egalitarian objection to prioritizing treatment on the basis of patients’ usefulness to others is best thought…